Regeneron Hires Firm to Market Former Avon R&D Facility in Suffern for Sale or Lease
Regeneron Pharmaceuticals abandoned plans last November to spend $139 million to renovate the former Avon Products facility it had acquired in December 2023 for $38,875,000 from Avon Capital Corp.